<div id="readability-page-1"><p>WINTON GROUP Ltd purchased a new position in shares of  Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 146,030 shares of the company's stock, valued at approximately $2,098,000. WINTON GROUP Ltd owned about 0.06% of Oscar Health at the end of the most recent reporting period.</p><ul><li>5 Small Cap Stocks With Explosive Upside Potential</li></ul><p>Several other institutional investors and hedge funds have also bought and sold shares of OSCR. Jones Financial Companies Lllp grew its position in  Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter.  Strs Ohio bought a new stake in shares of  Oscar Health in the 1st quarter worth approximately $30,000.  Fifth Third Bancorp grew its position in shares of  Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock worth $34,000 after buying an additional 1,413 shares during the last quarter.  Quarry LP grew its position in shares of  Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock worth $34,000 after buying an additional 1,469 shares during the last quarter.  Finally, Binnacle Investments Inc bought a new stake in shares of  Oscar Health in the 2nd quarter worth approximately $75,000. 75.70% of the stock is currently owned by institutional investors. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of equities research analysts have recently weighed in on the company. Wells Fargo &amp; Company  set a $20.00 price objective on Oscar Health and gave the stock an &#34;equal weight&#34; rating in a research report on Thursday. Robert W. Baird lifted their price objective on Oscar Health from $15.00 to $19.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, May 7th. Jefferies Financial Group upgraded Oscar Health from an &#34;underperform&#34; rating to a &#34;hold&#34; rating and lifted their price objective for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. UBS Group lifted their price objective on Oscar Health from $15.00 to $20.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, May 7th. Finally, Barclays lifted their price objective on Oscar Health from $21.00 to $30.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Tuesday, May 26th. One research analyst  has rated the stock with a Strong Buy rating, two have issued  a Buy rating, eight have assigned  a Hold rating and one  has given a Sell rating to the company's stock. Based on data from MarketBeat, the company  has an average rating of &#34;Hold&#34; and an average target price of $20.22.</p><p><b>Get Our Latest Report on OSCR</b></p><h2>Oscar Health Trading Up 0.3%</h2><p>OSCR opened at $24.59 on Monday. The stock has a market cap of $7.41 billion, a PE ratio of -41.68, a PEG ratio of 1.71 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The business has a 50 day moving average of $18.39 and a 200-day moving average of $16.07. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $25.58. </p><p>Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to analysts' expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm's revenue for the quarter was up 52.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.92 EPS.  Equities research analysts predict that  Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year. </p><h2>Key Headlines Impacting Oscar Health</h2><p>Here are the key news stories impacting Oscar Health this week:</p><ul>   <li><span>Positive Sentiment: </span>Wells Fargo upgraded Oscar Health from <strong>“strong sell” to “hold”</strong>, easing bearish sentiment even though its $20 target remains below the current share price. <i></i><span>Zacks.com</span></li>   <li><span>Positive Sentiment: </span>Oscar Health’s recent earnings showed a <strong>major EPS beat</strong>, which supports the stock’s fundamental story despite revenue coming in below estimates.</li>   <li><span>Neutral Sentiment: </span>A company co-founder shifting into an <strong>advisory leadership role</strong> looks like an internal reorganization rather than a disruptive change. <i></i><span>Oscar Health Co-Founder Shifts to Advisory Leadership Role</span></li>   <li><span>Neutral Sentiment: </span>Multiple insiders, including <strong>CFO Richard Scott Blackley</strong> and <strong>CAO Victoria Baltrus</strong>, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.</li>   <li><span>Negative Sentiment: </span>Director <strong>Mario Schlosser</strong> sold <strong>34,120 shares</strong>, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.</li> </ul><h2>Insider Buying and Selling</h2><p>In other news, insider Adam Mcananey sold 9,859 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. This trade represents a 4.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 100,000 shares of the firm's stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total value of $2,316,000.00. Following the completion of the transaction, the chief financial officer owned 1,216,660 shares of the company's stock, valued at approximately $28,177,845.60. The trade was a 7.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 189,660 shares of company stock worth $4,283,140 over the last quarter. Company insiders own  25.11% of the company's stock. </p><h2>Oscar Health Company Profile</h2> (Free Report)<p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.  </p><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Oscar Health</li><li>These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?</li><li>3 Stocks Under $20 to Buy Before a Broader Market Rally</li><li>Petco Faces Tough Competition, But Momentum Is Building</li><li>The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It</li></ul><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2><p>Before you consider Oscar Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

OSCR

OSCG

OSCX

<p>WINTON GROUP Ltd initiated a $2.10 million position in Oscar Health (OSCR) during Q4, purchasing 146,030 shares per SEC filings. Institutional ownership stands at 75.7%. Analysts recently adjusted price targets and ratings: Wells Fargo set a $20 target with an 'equal weight' rating, while UBS raised its target to $20. The average analyst rating is 'Hold' with a $20.22 target. Oscar Health recently reported Q1 EPS of $2.07, beating estimates, though revenue missed.</p>

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

Fifth Third Bancorp

Wells Fargo

Jefferies Financial

UBS Group AG

Barclays

Fifth Third Bancorp Pref Share FITBO 4.95 Perp 09/30/24 K

FIFTH THIRD BANK PREF SHARE FITB V6.625 P12/31/49 I

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

Fifth Third Bancorp Depositary Shs B Ser A Repr 1/40 6 % Perp Pfd Registered Shs B Ser A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

WINTON GROUP Ltd Takes $2.10 Million Position in Oscar Health, Inc. $OSCR